0	PROTEIN1 and PROTEIN were diminished in the sera of PROTEIN2-/- mice exposed to Propionibacterium acnes and lipopolysaccharide .
0	PROTEIN expressed in an PROTEIN1-dependent mouse pro-B cell line ( Ba/F3 ) binds PROTEIN with high affinity ( 200 to 250 pM ) , and the transfected cells exhibit a proliferative response to PROTEIN2 .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/PROTEIN1 and BR-II/BR-Ib ) and homomeric ( PROTEIN2/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	This transcriptional activity is inhibited by association with the PROTEIN1 ( PROTEIN ) or its relatives PROTEIN and PROTEIN2 .
0	Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN binding , although with variable potencies ; maximal PROTEIN binding inhibition was 80 % for PROTEIN , but only 30 % for PROTEIN1PROTEIN2 binding , although with variable potencies ; maximal PROTEIN binding inhibition was 80 % for PROTEIN , but only 30 % for PROTEIN .
0	In a number of human T cell clones , expression of PROTEIN1 mRNA is down-regulated after activation of the cells with anti-PROTEIN2 Ab and phorbol ester .
0	These findings imply that PROTEIN and PROTEIN1 share similar early signaling events with the possibility of using the same signal transducer , PROTEIN2 .
0	PROTEIN binding significantly increased hetero- and homo-oligomerization ( except for the PROTEIN homo-oligomer , which binds ligand poorly in the absence of PROTEIN1PROTEIN2 binding significantly increased hetero- and homo-oligomerization ( except for the PROTEIN homo-oligomer , which binds ligand poorly in the absence of PROTEIN ) .
0	Both PROTEIN1 and PROTEIN bind to all PROTEIN2 family members in vivo , and each complex is capable of activating transcription .
0	These data are consistent with a model wherein PROTEIN1/CDK complexes sequester the PROTEIN2-dependent kinase inhibitory activity of PROTEIN .
0	CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor PROTEIN1 ( also known as the PROTEIN2/RANTES receptor ) .
0	The first cDNA from the PROTEIN1 family to be cloned was designated PROTEIN , and multiple PROTEIN2 family members have now been identified .
0	PROTEIN1 suppressed c-jun-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells , whereas this suppression of apoptosis is attenuated by mutation in PROTEIN2 .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1PROTEIN2 ( PROTEIN SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN1PROTEIN2 could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN .
1	Yeast two-hybrid assay , GST binding assay and immunoprecipitation demonstrated that PROTEIN1 interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of PROTEIN2 , but not with that of PROTEIN .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN1 , and PROTEIN competed for binding with PROTEIN2 , indicating that PROTEIN uses components of the PROTEIN receptor .
1	We screened proteins for interaction with PROTEIN1 , and cloned the full-length cDNA of human PROTEIN2 , which encoded 1225 amino acids .
0	PROTEIN , a member of the spectrin/dystrophin family of PROTEIN1PROTEIN2 , a member of the spectrin/dystrophin family of actin-binding proteins , is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN .
0	PROTEIN1PROTEIN2 was derived by linking the two peptide chains of the PROTEIN dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue .
1	In vitro and in nonproliferating cells , PROTEIN1 associates with and inhibits cyclin/cycin-dependent kinase ( CDK ) holoenzymes containing either PROTEIN2 , PROTEIN , or PROTEIN .
0	PROTEIN1 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor PROTEIN2 ( also known as the MIP-1 alpha/RANTES receptor ) .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN1 and PROTEIN2 in the incorporation of U2 snRNP into the spliceosome .
0	Eosinophils undergo chemotaxis , degranulate , and exhibit [ C2+ ] i changes in response to the human CC chemokines macrophage inflammatory protein PROTEIN1 , regulated on activation , normal T expressed and secreted ( PROTEIN ) , and PROTEIN2 ( PROTEIN ) , but the receptors involved have not been defined .
0	The substrate specificity , the expression pattern of this kinase , and the ability to deplete 50 % of this kinase activity with a CDK6-specific antibody suggest that the PROTEIN protein mediates , in part , the PROTEIN1PROTEIN2 protein mediates , in part , the p27-associated Rb-kinase activity .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/PROTEIN1 ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , PROTEIN2/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	The AB loops of PROTEIN SC1 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the IFN-gamma/PROTEIN1PROTEIN2 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex .
0	Presenilin 1 suppresses the function of PROTEIN homodimers via interaction with PROTEIN1PROTEIN2 homodimers via interaction with QM/Jif-1 .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/PROTEIN1PROTEIN2/Jif-1 .
0	Monoclonal antibodies to the beta chain of the PROTEIN1 receptor inhibited the biological activity of PROTEIN , and PROTEIN competed for binding with PROTEIN2 , indicating that PROTEIN uses components of the PROTEIN receptor .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and PROTEIN1/BR-Ib ) and homomeric ( PROTEIN2/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Expression cloning and characterization of a human PROTEIN1PROTEIN2 .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , PROTEIN1/ PROTEIN , PROTEIN2/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( PROTEIN1/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , PROTEIN2/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Involvement of PROTEIN signal transducer PROTEIN in PROTEIN1PROTEIN2 in IL-11-mediated signal transduction .
0	Collectively , the novel function of PROTEIN1 via QM/PROTEIN2 influences c-jun-mediated transcription and apoptosis .
0	PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN1PROTEIN2 binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the NMDA receptor , and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain .
0	In contrast , PROTEIN complexes containing PROTEIN are incapable of phosphorylating PROTEIN1PROTEIN2 are incapable of phosphorylating histone H1 .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN1PROTEIN2 SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN1PROTEIN2 ( PROTEIN SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	We have previously identified PROTEIN1 specific binding protein which is distinct from that of PROTEIN2 in a number of cell lines .
0	Yeast two-hybrid assay , GST binding assay and immunoprecipitation demonstrated that PROTEIN interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of PROTEIN , but not with that of PROTEIN1PROTEIN2 interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of PROTEIN , but not with that of PROTEIN .
0	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN1PROTEIN2 with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN .
0	PROTEIN was first characterized as a receptor for PROTEIN , PROTEIN , and PROTEIN1PROTEIN2 , and PROTEIN , and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus ( HIV ) -1 strains and simian immunodeficiency virus ( SIV ) .
0	Isothermal titration calorimetry shows that PROTEIN1 forms a 1:1 complex with its high-affinity receptor ( PROTEIN2 R alpha ) with an affinity of 27 ( +/- 9 ) nM .
1	Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN binding , although with variable potencies ; maximal PROTEIN1 binding inhibition was 80 % for PROTEIN2 , but only 30 % for PROTEIN .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( PROTEIN1/BR-II , BR-Ia/ PROTEIN , PROTEIN2/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and PROTEIN1/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , PROTEIN2/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	This transcriptional activity is inhibited by association with the PROTEIN1 ( PROTEIN2 ) or its relatives PROTEIN and PROTEIN .
0	It was observed that anti-gp130 antibodies abolished cell proliferation , protein tyrosine phosphorylation , and PROTEIN gene expression elicited by PROTEIN or PROTEIN1PROTEIN2 gene expression elicited by PROTEIN or PROTEIN in TF-1 cells .
0	We also found another PROTEIN1 , PROTEIN , interacted with PROTEIN2 .
1	In addition , PROTEIN1 associates with three different CDKs : PROTEIN2 , PROTEIN , and PROTEIN .
0	The substrate specificity , the expression pattern of this kinase , and the ability to deplete 50 % of this kinase activity with a CDK6-specific antibody suggest that the PROTEIN protein mediates , in part , the p27-associated PROTEIN1PROTEIN2-specific antibody suggest that the PROTEIN protein mediates , in part , the p27-associated Rb-kinase activity .
0	Furthermore , the 60-kilodalton subunit of PROTEIN1 is related to the yeast splicing protein PROTEIN2 .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN1PROTEIN2 , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	However , MIP-1 beta was also an agonist for PROTEIN1 but not PROTEIN2 ; PROTEIN was an agonist for CC CKR1 but not CC CKR3 .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN and PROTEIN1 in the incorporation of PROTEIN2 into the spliceosome .
0	However , the various PROTEIN1/DP complexes display strong differences in the ability to bind to either PROTEIN2 or PROTEIN in vivo , and the specificity of PROTEIN or PROTEIN binding is mediated by the PROTEIN subunit .
0	In vitro and in nonproliferating cells , PROTEIN associates with and inhibits cyclin/cycin-dependent kinase ( CDK ) holoenzymes containing either PROTEIN , PROTEIN , or PROTEIN1PROTEIN2 , PROTEIN , or PROTEIN .
0	Lipopolysaccharide-activated PROTEIN1-deficient ( ICE-/- ) Kupffer cells synthesized the PROTEIN2 precursor but failed to process it into the active form .
0	The AB loops of PROTEIN SC1 adopt conformations similar to the ordered loops of PROTEIN1PROTEIN2 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex .
0	PROTEIN1 suppressed PROTEIN2-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells , whereas this suppression of apoptosis is attenuated by mutation in PROTEIN .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/PROTEIN1 , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN2 , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN1 and PROTEIN in the incorporation of PROTEIN2 into the spliceosome .
0	Coexpression of the alpha and betaL subunits of the human PROTEIN1 ( PROTEIN ) receptor is required for the induction of an antiviral state by human PROTEIN2 .
0	The structure also reveals the final six C-terminal amino acid residues of PROTEIN1 ( residues 253-258 ) that have not been observed in any other reported PROTEIN2 structures .
0	Isothermal titration calorimetry shows that PROTEIN SC1 forms a 1:1 complex with its high-affinity receptor ( PROTEIN1PROTEIN2 ) with an affinity of 27 ( +/- 9 ) nM .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1PROTEIN2 ( PROTEIN R alpha ) has been designed and characterized .
1	We screened for proteins that bind to PROTEIN1 from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the PROTEIN2/Jif-1 gene .
0	The structure also reveals the final six C-terminal amino acid residues of PROTEIN1 SC1 ( residues 253-258 ) that have not been observed in any other reported PROTEIN2 structures .
0	PROTEIN1 was derived by linking the two peptide chains of the PROTEIN2 dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue .
1	PROTEIN1 was first characterized as a receptor for PROTEIN , PROTEIN2 , and PROTEIN , and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus ( HIV ) -1 strains and simian immunodeficiency virus ( SIV ) .
0	All CC-chemokines currently available were tested for their ability to compete with [ ( 125 ) I ] -PROTEIN1 binding on a stable cell line expressing recombinant PROTEIN2 , and/or to induce a functional response in these cells .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1 ( PROTEIN2 ) has been designed and characterized .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( PROTEIN1/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN2 , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	The amount of PROTEIN and PROTEIN1 associated with PROTEIN does not change in a cell cycle-dependent fashion ; in contrast , the amount of PROTEIN associated with PROTEIN2 is lowest in early G1 cells and increases to a maximum in mid-G1 phase , reaching a steady-state level in late G1-phase cells .
0	Collectively , the novel function of PROTEIN via PROTEIN1/Jif-1 influences PROTEIN2-mediated transcription and apoptosis .
0	One clone encodes a novel PROTEIN1 catalytic subunit ( PP-1 alpha 2 ) , which differs from the originally defined PROTEIN2 by an amino-terminal 11-amino-acid insert .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	PROTEIN was first characterized as a receptor for PROTEIN1 , PROTEIN2 , and PROTEIN , and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus ( HIV ) -1 strains and simian immunodeficiency virus ( SIV ) .
0	It was observed that anti-gp130 antibodies abolished cell proliferation , protein tyrosine phosphorylation , and PROTEIN gene expression elicited by PROTEIN or PROTEIN1PROTEIN2 or PROTEIN in TF-1 cells .
0	PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN1PROTEIN2 binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the NMDA receptor , and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain .
1	Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN binding , although with variable potencies ; maximal PROTEIN1 binding inhibition was 80 % for PROTEIN , but only 30 % for PROTEIN2 .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN , and PROTEIN1 competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN2 .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/PROTEIN1PROTEIN2 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
1	Competitive binding of PROTEIN1 and PROTEIN to the PROTEIN2 .
1	As observed with the homologous Drosophila proteins , PROTEIN interacts directly with PROTEIN ; however , additional interactions between PROTEIN1 and PROTEIN2 or PROTEIN were detected .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/PROTEIN1 and PROTEIN2/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	PROTEIN , a member of the spectrin/PROTEIN1 family of PROTEIN2-binding proteins , is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN .
0	One clone encodes a novel type 1 protein phosphatase catalytic subunit ( PROTEIN1 ) , which differs from the originally defined PROTEIN2 by an amino-terminal 11-amino-acid insert .
1	We show that the physical interaction between PROTEIN and PROTEIN1 , a coactivator for PROTEIN2 , is not sufficient for repression of CREB-mediated transcription .
0	However , MIP-1 beta was also an agonist for CC CKR3 but not CC CKR1 ; PROTEIN was an agonist for CC CKR1 but not PROTEIN1PROTEIN2 was an agonist for CC CKR1 but not CC CKR3 .
0	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN1PROTEIN2 had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN1PROTEIN2 , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Yeast two-hybrid assay , GST binding assay and immunoprecipitation demonstrated that PROTEIN interacted with a hydrophilic loop region in the endoproteolytic C-terminal fragment of PROTEIN1 , but not with that of PROTEIN2 .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN , and PROTEIN competed for binding with PROTEIN1 , indicating that PROTEIN2 uses components of the PROTEIN receptor .
0	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN1PROTEIN2 with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN .
1	PROTEIN1 suppresses the function of PROTEIN homodimers via interaction with QM/PROTEIN2 .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by PROTEIN1PROTEIN2 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
0	A mutant form of human PROTEIN ( PROTEIN1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN2 R alpha ) has been designed and characterized .
0	Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN binding , although with variable potencies ; maximal PROTEIN binding inhibition was 80 % for PROTEIN , but only 30 % for PROTEIN1PROTEIN2 , but only 30 % for PROTEIN .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S PROTEIN1PROTEIN2 interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN and PROTEIN in the incorporation of U2 snRNP into the spliceosome .
1	A mutant form of human PROTEIN ( PROTEIN1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN2 ) has been designed and characterized .
0	These results suggest that PROTEIN1 and PROTEIN2 partly differ in function .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/PROTEIN1PROTEIN2 but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
0	PROTEIN was first characterized as a receptor for PROTEIN , PROTEIN , and PROTEIN1PROTEIN2 , PROTEIN , and PROTEIN , and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus ( HIV ) -1 strains and simian immunodeficiency virus ( SIV ) .
1	We have identified an 18-amino acid residue stretch in the PROTEIN1 head that is conserved only among type II epidermal keratins and that appears to play some role in PROTEIN2 tail binding .
0	Because PROTEIN inhibits macrophage activation by PROTEIN1PROTEIN2 inhibits macrophage activation by PROTEIN , this relationship suggests possible shared receptor or signal transduction pathway components .
0	We found that in addition to PROTEIN1 , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN binding , although with variable potencies ; maximal PROTEIN1PROTEIN2 binding , although with variable potencies ; maximal PROTEIN binding inhibition was 80 % for PROTEIN , but only 30 % for PROTEIN .
1	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( PROTEIN1/PROTEIN2 and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( PROTEIN1/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN2 , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Mouse PROTEIN1 does not bind to PROTEIN , and PROTEIN2-expressing Ba/F3 cells do not respond to the mouse cytokine , observations consistent with the known species specificity of PROTEIN .
0	However , PROTEIN1 was also an agonist for CC CKR3 but not CC CKR1 ; PROTEIN was an agonist for CC CKR1 but not PROTEIN2 .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN1 to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN2 into the spliceosome .
1	We found that in addition to PROTEIN1 , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -PROTEIN2 binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Finally , anti-IL-6R antibody inhibited the ability of PROTEIN , but not PROTEIN1PROTEIN2 antibody inhibited the ability of PROTEIN , but not PROTEIN , to transduce early signals in TF-1 cells .
0	However , MIP-1 beta was also an agonist for PROTEIN1 but not CC CKR1 ; PROTEIN2 was an agonist for CC CKR1 but not CC CKR3 .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN , and PROTEIN1 competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN2 receptor .
0	Mouse PROTEIN1 does not bind to PROTEIN2 , and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine , observations consistent with the known species specificity of PROTEIN .
1	The PROTEIN ( PROTEIN1 ) converting enzyme ( PROTEIN2 ) processes the inactive PROTEIN precursor to the proinflammatory cytokine .
0	Here it is shown that the PROTEIN1 subunits correspond to three of the 17S PROTEIN2-specific polypeptides .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/PROTEIN1PROTEIN2 but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/PROTEIN1PROTEIN2/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
0	Eosinophils undergo chemotaxis , degranulate , and exhibit [ C2+ ] i changes in response to the human CC chemokines macrophage inflammatory protein ( PROTEIN ) -1 alpha , regulated on activation , normal T expressed and secreted ( PROTEIN1 ) , and monocyte chemoattractant protein-3 ( PROTEIN2 ) , but the receptors involved have not been defined .
0	We next tested whether PROTEIN induced signaling can be inhibited by anti-gp130 antibodies which blocked PROTEIN1PROTEIN2 antibodies which blocked IL-6-mediated functions .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN1 , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Involvement of PROTEIN1 signal transducer PROTEIN2 in IL-11-mediated signal transduction .
0	The PROTEIN1PROTEIN2 ( PROTEIN ) converting enzyme ( PROTEIN ) processes the inactive PROTEIN precursor to the proinflammatory cytokine .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN1PROTEIN2 SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/PROTEIN1 , BR-Ia/ PROTEIN , PROTEIN2/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN1PROTEIN2/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	The substrate specificity , the expression pattern of this kinase , and the ability to deplete 50 % of this kinase activity with a CDK6-specific antibody suggest that the PROTEIN protein mediates , in part , the PROTEIN1PROTEIN2-specific antibody suggest that the PROTEIN protein mediates , in part , the p27-associated Rb-kinase activity .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN1 to generate a structure similar to 17S PROTEIN2 , which suggests a function for PROTEIN and PROTEIN in the incorporation of U2 snRNP into the spliceosome .
0	When [ Ca2+ ] i changes were monitored in stably transfected human embryonic kidney 293 cells , PROTEIN1 PROTEIN and PROTEIN2 were both potent agonists for CC CKR3 and CC CKR1 .
0	The crystal structure of PROTEIN1PROTEIN2 has been determined at 2.9 A resolution from crystals grown in 1.4 M citrate solutions at pH 7.6 .
0	Our results demonstrated that the first 82 amino acids ( AAs ) ( AAs 265-346 ) of the cytoplasmic domain of the betaL chain are sufficient to activate the PROTEIN1-Stat pathway and trigger an antiviral state after PROTEIN2 binding to the receptor .
0	Here we show that PROTEIN1/PROTEIN2 , a negative regulator of PROTEIN , is a candidate to mediate the function of PROTEIN in the cell .
0	We found that in addition to PROTEIN1 , PROTEIN2 , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Interaction of mammalian splicing factor PROTEIN with U2 snRNP and relation of its 60-kD subunit to yeast PROTEIN1PROTEIN2 and relation of its 60-kD subunit to yeast PROTEIN .
0	Here we show that PROTEIN1/Jun-interacting factor ( Jif ) -1 , a negative regulator of PROTEIN , is a candidate to mediate the function of PROTEIN2 in the cell .
1	A region of the beta subunit of the PROTEIN1 different from box 1 interacts with PROTEIN2 and is sufficient to activate the Jak-Stat pathway and induce an antiviral state .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , PROTEIN1/ PROTEIN , BR-Ib/ PROTEIN , and also PROTEIN2/ PROTEIN ) oligomers in the absence of ligand .
0	We found that in addition to PROTEIN1 , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	The predicted amino acid sequence of PROTEIN1 is 60 % identical and 73 % similar to mouse PROTEIN2 ( PROTEIN ) .
0	PROTEIN was also shown to cleave the precursor of PROTEIN1PROTEIN2 ( PROTEIN ) at the authentic processing site with high efficiency , thereby activating PROTEIN and facilitating its export .
0	PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN1 subunits of the NMDA receptor , and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain .
1	PROTEIN binding significantly increased hetero- and homo-oligomerization ( except for the PROTEIN1 homo-oligomer , which binds ligand poorly in the absence of PROTEIN2 ) .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Intriguingly , PROTEIN1-PROTEIN2 binding is directly antagonized by Ca2+/calmodulin .
0	When [ Ca2+ ] i changes were monitored in stably transfected human embryonic kidney 293 cells , ( PROTEIN ) -1 alpha PROTEIN1 and PROTEIN were both potent agonists for CC CKR3 and PROTEIN2 .
0	Activation of PROTEIN1 inducing factor mediated by PROTEIN2 .
0	We found that in addition to PROTEIN , PROTEIN1 , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
1	When [ Ca2+ ] i changes were monitored in stably transfected human embryonic kidney 293 cells , ( PROTEIN ) -1 alpha PROTEIN and PROTEIN1 were both potent agonists for CC CKR3 and PROTEIN2 .
0	PROTEIN1 was also shown to cleave the precursor of PROTEIN2 inducing factor ( PROTEIN ) at the authentic processing site with high efficiency , thereby activating PROTEIN and facilitating its export .
1	In contrast , PROTEIN1 complexes containing PROTEIN2 are incapable of phosphorylating histone H1 .
0	PROTEIN1 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 ( also known as the PROTEIN2/RANTES receptor ) .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1PROTEIN2 receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	Presenilin 1 suppresses the function of PROTEIN homodimers via interaction with QM/PROTEIN1PROTEIN2/Jif-1 .
1	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN1 by PROTEIN2 and may therefore be considered as a natural antagonist for PROTEIN .
0	PROTEIN1 is a novel cytokine with a variety of biofunctions which overlap with those of PROTEIN2 .
0	Presenilin 1 ( PROTEIN1PROTEIN2 ( PROTEIN ) is the causative gene for an autosomal dominant familial Alzheimer 's disease ( AD ) mapped to chromosome 14 .
0	This transcriptional activity is inhibited by association with the retinoblastoma tumor suppressor protein ( PROTEIN1 ) or its relatives PROTEIN2 and PROTEIN .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1PROTEIN2 ( PROTEIN SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN1 and PROTEIN subunits of the PROTEIN2 , and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain .
0	It was observed that anti-gp130 antibodies abolished cell proliferation , protein tyrosine phosphorylation , and PROTEIN1PROTEIN2 antibodies abolished cell proliferation , protein tyrosine phosphorylation , and PROTEIN gene expression elicited by PROTEIN or PROTEIN in TF-1 cells .
0	CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 ( also known as the MIP-1 alpha/PROTEIN1PROTEIN2 ( also known as the MIP-1 alpha/RANTES receptor ) .
1	Among these ligands , PROTEIN1 had the remarkable property of binding PROTEIN2 with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN .
1	The AB loops of PROTEIN SC1 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the PROTEIN1/PROTEIN2 complex .
0	When [ Ca2+ ] i changes were monitored in stably transfected human embryonic kidney 293 cells , ( PROTEIN ) -1 alpha PROTEIN and PROTEIN were both potent agonists for PROTEIN1 and PROTEIN2 .
1	In addition , PROTEIN1 associates with three different CDKs : PROTEIN , PROTEIN2 , and PROTEIN .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1PROTEIN2 ( PROTEIN SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	PROTEIN was also shown to cleave the precursor of PROTEIN inducing factor ( PROTEIN1 ) at the authentic processing site with high efficiency , thereby activating PROTEIN2 and facilitating its export .
0	Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN1PROTEIN2 binding could also compete for monomeric PROTEIN binding , although with variable potencies ; maximal PROTEIN binding inhibition was 80 % for PROTEIN , but only 30 % for PROTEIN .
0	Mouse PROTEIN does not bind to PROTEIN1 , and PROTEIN2-expressing Ba/F3 cells do not respond to the mouse cytokine , observations consistent with the known species specificity of PROTEIN .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN1 to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN2 and PROTEIN in the incorporation of U2 snRNP into the spliceosome .
0	Using several complementary approaches , we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors ( PROTEIN and PROTEIN ) and the BMP type II receptor ( PROTEIN1PROTEIN2 ) and the BMP type II receptor ( PROTEIN ) .
0	The binding of PROTEIN1/PROTEIN2 to full-length PROTEIN was confirmed in vitro by pull-down assay , and in vivo by immunoprecipitation assays with human samples , including AD brains .
0	The similarities in biofunctions and differences in ligand binding proteins between PROTEIN1 and PROTEIN2 prompted us to investigate whether PROTEIN shares common signal transduction mechanisms with PROTEIN .
1	Despite binding to only one PROTEIN1 , PROTEIN2 is biologically active in cell proliferation , MHC class I induction , and anti-viral assays .
0	Finally , anti-IL-6R antibody inhibited the ability of PROTEIN , but not PROTEIN1PROTEIN2 , but not PROTEIN , to transduce early signals in TF-1 cells .
0	The AB loops of PROTEIN SC1 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the IFN-gamma/PROTEIN1PROTEIN2 observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex .
1	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , PROTEIN1/ PROTEIN2 , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN1PROTEIN2 R alpha and PROTEIN R beta into a complex competent for eliciting biological activity .
0	However , PROTEIN1 was also an agonist for CC CKR3 but not PROTEIN2 ; PROTEIN was an agonist for CC CKR1 but not CC CKR3 .
1	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -PROTEIN1 binding : PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , PROTEIN1/ PROTEIN , BR-Ib/ PROTEIN2 , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	When [ Ca2+ ] i changes were monitored in stably transfected human embryonic kidney 293 cells , ( PROTEIN ) -1 alpha PROTEIN1 and PROTEIN were both potent agonists for PROTEIN2 and CC CKR1 .
1	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by PROTEIN1/PROTEIN2 heterodimers , consistent with the reported function of QM/Jif-1 .
0	This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN R alpha and PROTEIN1PROTEIN2 into a complex competent for eliciting biological activity .
0	By monitoring fluorescent recombinant protein and by gel mobility shift assays , PROTEIN was shown to accelerate the translocation of PROTEIN from the cytoplasm to the nucleus and to thereby suppress the binding of PROTEIN1PROTEIN2 from the cytoplasm to the nucleus and to thereby suppress the binding of PROTEIN homodimer to 12-O-tetradecanoylphorbol-13- acetate ( TPA ) -responsive element ( TRE ) .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1 receptor alpha chain ( PROTEIN2 ) has been designed and characterized .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN1PROTEIN2 ( PROTEIN SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	The PROTEIN1 ( PROTEIN2 ) interacts with many cellular proteins in complexes potentially important for its growth-suppressing function .
1	However , PROTEIN1 was also an agonist for PROTEIN2 but not CC CKR1 ; PROTEIN was an agonist for CC CKR1 but not CC CKR3 .
0	Intriguingly , NR1-PROTEIN1 binding is directly antagonized by Ca2+/PROTEIN2 .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/PROTEIN1 ) and homomeric ( BR-II/BR-II , PROTEIN2/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	PROTEIN suppressed c-jun-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells , whereas this suppression of apoptosis is attenuated by mutation in PROTEIN1PROTEIN2-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells , whereas this suppression of apoptosis is attenuated by mutation in PROTEIN .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( PROTEIN1/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN2 , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1 alpha chain ( PROTEIN2 R alpha ) has been designed and characterized .
0	By monitoring fluorescent recombinant protein and by gel mobility shift assays , PROTEIN was shown to accelerate the translocation of PROTEIN1PROTEIN2 was shown to accelerate the translocation of PROTEIN from the cytoplasm to the nucleus and to thereby suppress the binding of PROTEIN homodimer to 12-O-tetradecanoylphorbol-13- acetate ( TPA ) -responsive element ( TRE ) .
0	This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN1PROTEIN2 is sufficient to recruit PROTEIN R alpha and PROTEIN R beta into a complex competent for eliciting biological activity .
0	A mutant form of human PROTEIN ( PROTEIN1PROTEIN2 SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	Both PROTEIN and PROTEIN1 bind to all PROTEIN2 family members in vivo , and each complex is capable of activating transcription .
0	These results demonstrate that PROTEIN1 and PROTEIN2 utilize different ligand binding proteins , but share common signal transducer , PROTEIN , in TF-1 cells .
0	PROTEIN was also shown to cleave the precursor of PROTEIN1 ( PROTEIN2 ) at the authentic processing site with high efficiency , thereby activating PROTEIN and facilitating its export .
0	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN1PROTEIN2 by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN .
0	Comparison of the wild-type receptor-binding domain and the Asp111-containing domain of PROTEIN1PROTEIN2 SC1 show that they are structurally equivalent but have very different electrostatic surface potentials .
0	PROTEIN1 , a member of the spectrin/dystrophin family of actin-binding proteins , is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN2 .
0	Like PROTEIN , PROTEIN1PROTEIN2 , PROTEIN is structurally related to PROTEIN .
0	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN1PROTEIN2 could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN .
0	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN1PROTEIN2 had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN .
0	However , MIP-1 beta was also an agonist for CC CKR3 but not PROTEIN1 ; PROTEIN was an agonist for PROTEIN2 but not CC CKR3 .
0	The amount of PROTEIN and PROTEIN1 associated with PROTEIN does not change in a cell cycle-dependent fashion ; in contrast , the amount of PROTEIN2 associated with PROTEIN is lowest in early G1 cells and increases to a maximum in mid-G1 phase , reaching a steady-state level in late G1-phase cells .
0	However , MIP-1 beta was also an agonist for CC CKR3 but not CC CKR1 ; PROTEIN was an agonist for CC CKR1 but not PROTEIN1PROTEIN2 but not CC CKR3 .
1	We show that the carboxy terminal `` tail '' of PROTEIN1 associates directly with the amino terminal `` head '' of type II epidermal keratins , including PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN .
1	The binding of QM/PROTEIN1 to full-length PROTEIN2 was confirmed in vitro by pull-down assay , and in vivo by immunoprecipitation assays with human samples , including AD brains .
1	Moreover , similar PROTEIN1 sequences are required for binding PROTEIN2 and SV40 large T antigen .
0	PROTEIN interacts with PROTEIN1 in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN2 into the spliceosome .
0	Immunoelectronmicroscopic analysis showed that PROTEIN1/PROTEIN2 and PROTEIN are colocalized at the endoplasmic reticulum , and the nuclear matrix in human brain neurons .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and PROTEIN1/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN2 , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
1	PROTEIN1 binding significantly increased hetero- and homo-oligomerization ( except for the PROTEIN2 homo-oligomer , which binds ligand poorly in the absence of PROTEIN ) .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by PROTEIN1PROTEIN2 but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of PROTEIN1PROTEIN2 heterodimers , consistent with the reported function of QM/Jif-1 .
1	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN1 uses components of the PROTEIN2 .
0	The PROTEIN ( PROTEIN ) converting enzyme ( PROTEIN1 ) processes the inactive PROTEIN2 precursor to the proinflammatory cytokine .
0	A mutant form of human PROTEIN ( PROTEIN1PROTEIN2 ( PROTEIN SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN binding , although with variable potencies ; maximal PROTEIN binding inhibition was 80 % for PROTEIN , but only 30 % for PROTEIN1PROTEIN2 binding could also compete for monomeric PROTEIN binding , although with variable potencies ; maximal PROTEIN binding inhibition was 80 % for PROTEIN , but only 30 % for PROTEIN .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1 receptor alpha chain ( PROTEIN2 R alpha ) has been designed and characterized .
0	The AB loops of PROTEIN SC1 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the IFN-gamma/PROTEIN1PROTEIN2 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex .
0	However , the various PROTEIN1/DP complexes display strong differences in the ability to bind to either PROTEIN or PROTEIN in vivo , and the specificity of PROTEIN2 or PROTEIN binding is mediated by the PROTEIN subunit .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/PROTEIN1 ) and homomeric ( PROTEIN2/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
1	Isolation of human PROTEIN1 and its binding specificity with PROTEIN2 .
0	The substrate specificity , the expression pattern of this kinase , and the ability to deplete 50 % of this kinase activity with a CDK6-specific antibody suggest that the PROTEIN protein mediates , in part , the p27-associated PROTEIN1PROTEIN2 protein mediates , in part , the p27-associated Rb-kinase activity .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/PROTEIN1 and BR-II/PROTEIN2 ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and PROTEIN1/BR-Ib ) and homomeric ( BR-II/PROTEIN2 , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	It was observed that anti-gp130 antibodies abolished cell proliferation , protein tyrosine phosphorylation , and PROTEIN gene expression elicited by PROTEIN1PROTEIN2 gene expression elicited by PROTEIN or PROTEIN in TF-1 cells .
0	Thus , PROTEIN1PROTEIN2 R alpha binding does not result in a large conformational change in the AB loop as previously suggested .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( PROTEIN1/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/PROTEIN2 , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Although many different types of proliferating cells contain PROTEIN1 protein , neither the interactions of PROTEIN2 with cyclin/CDK complexes nor the consequences of this interaction during the mitotic cycle have been fully explored .
0	The substrate specificity , the expression pattern of this kinase , and the ability to deplete 50 % of this kinase activity with a CDK6-specific antibody suggest that the PROTEIN protein mediates , in part , the p27-associated PROTEIN1PROTEIN2-associated Rb-kinase activity .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of PROTEIN1PROTEIN2/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
1	We show that the carboxy terminal `` tail '' of PROTEIN1 associates directly with the amino terminal `` head '' of type II epidermal keratins , including PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN .
1	The results showed that PROTEIN and PROTEIN1 can both stimulate cell proliferation , induce similar pattern of protein tyrosine phosphorylation , and activate the same proto-oncogene ( PROTEIN2 ) expression in TF-1 cells .
0	Mouse PROTEIN1 does not bind to PROTEIN , and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine , observations consistent with the known species specificity of PROTEIN2 .
1	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -PROTEIN1 binding : PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/PROTEIN1PROTEIN2 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
0	The amount of PROTEIN1 and PROTEIN associated with PROTEIN does not change in a cell cycle-dependent fashion ; in contrast , the amount of PROTEIN2 associated with PROTEIN is lowest in early G1 cells and increases to a maximum in mid-G1 phase , reaching a steady-state level in late G1-phase cells .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1PROTEIN2 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	However , MIP-1 beta was also an agonist for PROTEIN1 but not CC CKR1 ; PROTEIN was an agonist for CC CKR1 but not PROTEIN2 .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/PROTEIN1PROTEIN2/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
1	PROTEIN1 was also shown to cleave the precursor of PROTEIN inducing factor ( PROTEIN ) at the authentic processing site with high efficiency , thereby activating PROTEIN2 and facilitating its export .
1	PROTEIN1 was first characterized as a receptor for PROTEIN , PROTEIN , and PROTEIN2 , and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus ( HIV ) -1 strains and simian immunodeficiency virus ( SIV ) .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/PROTEIN1 and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN2 , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	A region of the beta subunit of the PROTEIN1 receptor different from box 1 interacts with PROTEIN2 and is sufficient to activate the Jak-Stat pathway and induce an antiviral state .
0	The results showed that PROTEIN1 and PROTEIN2 can both stimulate cell proliferation , induce similar pattern of protein tyrosine phosphorylation , and activate the same proto-oncogene ( PROTEIN ) expression in TF-1 cells .
0	In contrast , PROTEIN complexes containing PROTEIN are incapable of phosphorylating PROTEIN1PROTEIN2 complexes containing PROTEIN are incapable of phosphorylating histone H1 .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/PROTEIN1 , PROTEIN2/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN1PROTEIN2 and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Using several complementary approaches , we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors ( PROTEIN and PROTEIN ) and the PROTEIN1PROTEIN2 ) and the BMP type II receptor ( PROTEIN ) .
0	The similarities in biofunctions and differences in ligand binding proteins between PROTEIN and PROTEIN prompted us to investigate whether PROTEIN1 shares common signal transduction mechanisms with PROTEIN2 .
0	Competitive binding of PROTEIN1 and PROTEIN2 to the NMDA receptor .
0	The AB loops of PROTEIN SC1 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the PROTEIN1PROTEIN2 observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex .
1	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN1 could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN2 .
1	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and PROTEIN1/PROTEIN2 ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
1	Interaction of mammalian splicing factor PROTEIN1 with PROTEIN2 and relation of its 60-kD subunit to yeast PROTEIN .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN1PROTEIN2 , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Monoclonal antibodies to the beta chain of the PROTEIN1 receptor inhibited the biological activity of PROTEIN , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN2 .
0	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN1PROTEIN2 and may therefore be considered as a natural antagonist for PROTEIN .
0	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN1PROTEIN2 had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN .
0	The PROTEIN1 ( PROTEIN2 ) processes the inactive PROTEIN precursor to the proinflammatory cytokine .
1	This suggests that one domain of PROTEIN1 is sufficient to recruit PROTEIN R alpha and PROTEIN2 into a complex competent for eliciting biological activity .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( PROTEIN1/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN2 ) oligomers in the absence of ligand .
0	The AB loops of PROTEIN SC1 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the PROTEIN1PROTEIN2 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/PROTEIN1 ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also PROTEIN2/ PROTEIN ) oligomers in the absence of ligand .
0	PROTEIN1 interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN2 into the spliceosome .
0	When [ Ca2+ ] i changes were monitored in stably transfected human embryonic kidney 293 cells , PROTEIN1 PROTEIN2 and PROTEIN were both potent agonists for CC CKR3 and CC CKR1 .
0	Like PROTEIN , PROTEIN is structurally related to PROTEIN1PROTEIN2 is structurally related to PROTEIN .
0	Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN binding , although with variable potencies ; maximal PROTEIN binding inhibition was 80 % for PROTEIN1PROTEIN2 binding could also compete for monomeric PROTEIN binding , although with variable potencies ; maximal PROTEIN binding inhibition was 80 % for PROTEIN , but only 30 % for PROTEIN .
0	The PROTEIN1 ( PROTEIN ) converting enzyme ( PROTEIN ) processes the inactive PROTEIN2 precursor to the proinflammatory cytokine .
0	The PROTEIN1 ( PROTEIN ) processes the inactive PROTEIN2 precursor to the proinflammatory cytokine .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1 ( PROTEIN2 R alpha ) has been designed and characterized .
0	In vitro and in nonproliferating cells , PROTEIN associates with and inhibits cyclin/cycin-dependent kinase ( CDK ) holoenzymes containing either PROTEIN , PROTEIN1 , or PROTEIN2 .
1	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -PROTEIN1 binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Coexpression of the alpha and betaL subunits of the human interferon alpha ( PROTEIN1 ) receptor is required for the induction of an antiviral state by human PROTEIN2 .
1	The amount of PROTEIN1 and PROTEIN associated with PROTEIN2 does not change in a cell cycle-dependent fashion ; in contrast , the amount of PROTEIN associated with PROTEIN is lowest in early G1 cells and increases to a maximum in mid-G1 phase , reaching a steady-state level in late G1-phase cells .
1	PROTEIN1 also interacts with PROTEIN , but it interacts more strongly with PROTEIN and PROTEIN2 .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/PROTEIN1PROTEIN2/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN1PROTEIN2 receptor inhibited the biological activity of PROTEIN , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN receptor .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN1PROTEIN2 uses components of the PROTEIN receptor .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	In addition , PROTEIN associates with three different CDKs : PROTEIN , PROTEIN1 , and PROTEIN2 .
1	PROTEIN1 was also shown to cleave the precursor of PROTEIN inducing factor ( PROTEIN2 ) at the authentic processing site with high efficiency , thereby activating PROTEIN and facilitating its export .
0	In vitro and in nonproliferating cells , PROTEIN associates with and inhibits cyclin/cycin-dependent kinase ( CDK ) holoenzymes containing either PROTEIN , PROTEIN1PROTEIN2 , PROTEIN , or PROTEIN .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN1PROTEIN2 with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN .
1	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -PROTEIN1 binding : PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/PROTEIN1 ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN2 , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
1	As observed with the homologous Drosophila proteins , PROTEIN interacts directly with PROTEIN ; however , additional interactions between PROTEIN1 and PROTEIN or PROTEIN2 were detected .
0	The current data are consistent with the main role of the PROTEIN dimer being to decrease the dissociation constant of PROTEIN1PROTEIN2 dimer being to decrease the dissociation constant of PROTEIN for its cellular receptors .
0	A region of the beta subunit of the interferon alpha receptor different from box 1 interacts with PROTEIN1 and is sufficient to activate the PROTEIN2-Stat pathway and induce an antiviral state .
0	We have isolated a human cDNA encoding the first eosinophil-selective chemokine receptor , designated CC chemokine receptor 3 ( PROTEIN1PROTEIN2 ( CC CKR3 ) .
0	The cytokine , designated PROTEIN ( PROTEIN ) , is produced by a wide variety of cells and tissues and shares many biological properties with PROTEIN1PROTEIN2 ) , is produced by a wide variety of cells and tissues and shares many biological properties with PROTEIN .
0	Intriguingly , PROTEIN1-alpha-actinin binding is directly antagonized by Ca2+/PROTEIN2 .
0	These findings imply that PROTEIN1 and PROTEIN2 share similar early signaling events with the possibility of using the same signal transducer , PROTEIN .
0	This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN R alpha and PROTEIN1PROTEIN2 R alpha and PROTEIN R beta into a complex competent for eliciting biological activity .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN , and PROTEIN1PROTEIN2 receptor inhibited the biological activity of PROTEIN , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN receptor .
0	PROTEIN1 binds multiple CC-chemokines : PROTEIN2 acts as a natural antagonist .
1	We found that in addition to PROTEIN , PROTEIN , and PROTEIN1 , five other CC-chemokines could compete for [ ( 125 ) I ] -PROTEIN2 binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1 alpha chain ( PROTEIN2 ) has been designed and characterized .
0	PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN1 and PROTEIN subunits of the NMDA receptor , and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/PROTEIN1PROTEIN2 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
0	The PROTEIN ( PROTEIN1PROTEIN2 ( PROTEIN ) processes the inactive PROTEIN precursor to the proinflammatory cytokine .
1	When [ Ca2+ ] i changes were monitored in stably transfected human embryonic kidney 293 cells , PROTEIN1 PROTEIN and PROTEIN were both potent agonists for PROTEIN2 and CC CKR1 .
0	Using several complementary approaches , we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors ( PROTEIN and PROTEIN ) and the PROTEIN1PROTEIN2 and PROTEIN ) and the BMP type II receptor ( PROTEIN ) .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( PROTEIN1/BR-Ia and BR-II/PROTEIN2 ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
1	Cloning and characterization of PROTEIN1 , PROTEIN2 and PROTEIN : three subunits of the human transcription factor TFIID .
0	The amount of PROTEIN and PROTEIN associated with PROTEIN1 does not change in a cell cycle-dependent fashion ; in contrast , the amount of PROTEIN2 associated with PROTEIN is lowest in early G1 cells and increases to a maximum in mid-G1 phase , reaching a steady-state level in late G1-phase cells .
0	PROTEIN expressed in an IL-3-dependent mouse pro-B cell line ( Ba/F3 ) binds PROTEIN1 with high affinity ( 200 to 250 pM ) , and the transfected cells exhibit a proliferative response to PROTEIN2 .
0	The similarities in biofunctions and differences in ligand binding proteins between PROTEIN1 and PROTEIN prompted us to investigate whether PROTEIN shares common signal transduction mechanisms with PROTEIN2 .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of PROTEIN1PROTEIN2 but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
0	We found that in addition to PROTEIN1 , PROTEIN , and PROTEIN2 , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
1	PROTEIN1 could compete efficiently for PROTEIN2 binding but was , however , found to be a weak inhibitor of HIV infection , probably as a consequence of its inability to downregulate the receptor .
0	Like PROTEIN , PROTEIN is structurally related to PROTEIN1PROTEIN2 , PROTEIN is structurally related to PROTEIN .
0	However , the various PROTEIN1/DP complexes display strong differences in the ability to bind to either PROTEIN or PROTEIN in vivo , and the specificity of PROTEIN or PROTEIN2 binding is mediated by the PROTEIN subunit .
0	Using several complementary approaches , we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors ( PROTEIN and PROTEIN ) and the BMP type II receptor ( PROTEIN1PROTEIN2 and PROTEIN ) and the BMP type II receptor ( PROTEIN ) .
0	A mutant form of human PROTEIN ( PROTEIN1PROTEIN2 ( PROTEIN SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN1PROTEIN2 ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	This transcriptional activity is inhibited by association with the retinoblastoma tumor suppressor protein ( PROTEIN ) or its relatives PROTEIN and PROTEIN1PROTEIN2 and PROTEIN .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( PROTEIN1/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also PROTEIN2/ PROTEIN ) oligomers in the absence of ligand .
0	We have examined early signals triggered by PROTEIN1 or PROTEIN2 in a multifactor-dependent human erythroleukemic cell line , TF-1 .
0	The amount of PROTEIN1 and PROTEIN2 associated with PROTEIN does not change in a cell cycle-dependent fashion ; in contrast , the amount of PROTEIN associated with PROTEIN is lowest in early G1 cells and increases to a maximum in mid-G1 phase , reaching a steady-state level in late G1-phase cells .
1	Moreover , similar PROTEIN1 sequences are required for binding PP-1 alpha 2 and PROTEIN2 .
1	When [ Ca2+ ] i changes were monitored in stably transfected human embryonic kidney 293 cells , PROTEIN1 PROTEIN and PROTEIN were both potent agonists for CC CKR3 and PROTEIN2 .
0	PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN1 subunits of the PROTEIN2 , and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain .
1	This suggests that one domain of PROTEIN1 is sufficient to recruit PROTEIN2 and PROTEIN R beta into a complex competent for eliciting biological activity .
1	The PROTEIN1 ( PROTEIN ) converting enzyme ( PROTEIN2 ) processes the inactive PROTEIN precursor to the proinflammatory cytokine .
1	We show that the carboxy terminal `` tail '' of PROTEIN1 associates directly with the amino terminal `` head '' of type II epidermal keratins , including PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN1 , and PROTEIN2 competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN receptor .
0	We next tested whether PROTEIN induced signaling can be inhibited by anti-gp130 antibodies which blocked PROTEIN1PROTEIN2 induced signaling can be inhibited by anti-gp130 antibodies which blocked IL-6-mediated functions .
0	One clone encodes a novel PROTEIN1 catalytic subunit ( PROTEIN2 ) , which differs from the originally defined PP-1 alpha by an amino-terminal 11-amino-acid insert .
0	However , MIP-1 beta was also an agonist for CC CKR3 but not PROTEIN1 ; PROTEIN was an agonist for CC CKR1 but not PROTEIN2 .
1	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also PROTEIN1/ PROTEIN2 ) oligomers in the absence of ligand .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/PROTEIN1 and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , PROTEIN2/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	The amount of PROTEIN1 and PROTEIN associated with PROTEIN does not change in a cell cycle-dependent fashion ; in contrast , the amount of PROTEIN associated with PROTEIN2 is lowest in early G1 cells and increases to a maximum in mid-G1 phase , reaching a steady-state level in late G1-phase cells .
0	The first cDNA from the PROTEIN1 family to be cloned was designated PROTEIN2 , and multiple PROTEIN family members have now been identified .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/PROTEIN1 and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN2 , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN1 , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN2 receptor .
0	The PROTEIN ( PROTEIN1PROTEIN2 ( PROTEIN ) converting enzyme ( PROTEIN ) processes the inactive PROTEIN precursor to the proinflammatory cytokine .
0	The first cDNA from the PROTEIN family to be cloned was designated PROTEIN1 , and multiple PROTEIN2 family members have now been identified .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/PROTEIN1 and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , PROTEIN2/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Despite binding to only one PROTEIN R alpha , PROTEIN1PROTEIN2 R alpha , PROTEIN SC1 is biologically active in cell proliferation , MHC class I induction , and anti-viral assays .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN1 to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN and PROTEIN2 in the incorporation of U2 snRNP into the spliceosome .
0	We found that in addition to PROTEIN , PROTEIN1 , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	PROTEIN was also shown to cleave the precursor of PROTEIN1 inducing factor ( PROTEIN2 ) at the authentic processing site with high efficiency , thereby activating PROTEIN and facilitating its export .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of PROTEIN1PROTEIN2/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
1	The results showed that PROTEIN1 and PROTEIN can both stimulate cell proliferation , induce similar pattern of protein tyrosine phosphorylation , and activate the same proto-oncogene ( PROTEIN2 ) expression in TF-1 cells .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN , and PROTEIN1 competed for binding with PROTEIN2 , indicating that PROTEIN uses components of the PROTEIN receptor .
0	We found that in addition to PROTEIN , PROTEIN1 , and PROTEIN2 , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	These data are consistent with a model wherein PROTEIN1/CDK complexes sequester the CDK2-dependent kinase inhibitory activity of PROTEIN2 .
0	A region of the beta subunit of the PROTEIN1 different from box 1 interacts with PROTEIN and is sufficient to activate the PROTEIN2-Stat pathway and induce an antiviral state .
0	Isothermal titration calorimetry shows that PROTEIN1 SC1 forms a 1:1 complex with its high-affinity receptor ( PROTEIN2 ) with an affinity of 27 ( +/- 9 ) nM .
0	PROTEIN interacts with PROTEIN1 in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN2 and PROTEIN in the incorporation of U2 snRNP into the spliceosome .
0	Here we show that QM/PROTEIN1 , a negative regulator of PROTEIN , is a candidate to mediate the function of PROTEIN2 in the cell .
1	PROTEIN1 expressed in an IL-3-dependent mouse pro-B cell line ( Ba/F3 ) binds PROTEIN2 with high affinity ( 200 to 250 pM ) , and the transfected cells exhibit a proliferative response to PROTEIN .
0	We found that in addition to PROTEIN1 , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN1 , and also PROTEIN2/ PROTEIN ) oligomers in the absence of ligand .
0	We found that in addition to PROTEIN , PROTEIN1 , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	When [ Ca2+ ] i changes were monitored in stably transfected human embryonic kidney 293 cells , ( PROTEIN ) -1 alpha PROTEIN1 and PROTEIN2 were both potent agonists for CC CKR3 and CC CKR1 .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , PROTEIN1/ PROTEIN , and also PROTEIN2/ PROTEIN ) oligomers in the absence of ligand .
0	We next tested whether PROTEIN induced signaling can be inhibited by anti-PROTEIN1PROTEIN2 induced signaling can be inhibited by anti-gp130 antibodies which blocked IL-6-mediated functions .
0	PROTEIN1 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 ( also known as the MIP-1 alpha/PROTEIN2 receptor ) .
0	However , PROTEIN1 was also an agonist for CC CKR3 but not CC CKR1 ; PROTEIN was an agonist for PROTEIN2 but not CC CKR3 .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN1PROTEIN2 receptor inhibited the biological activity of PROTEIN , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN receptor .
1	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( PROTEIN1/PROTEIN2 , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S PROTEIN1 , which suggests a function for PROTEIN2 and PROTEIN in the incorporation of U2 snRNP into the spliceosome .
1	In vitro and in nonproliferating cells , PROTEIN1 associates with and inhibits cyclin/cycin-dependent kinase ( CDK ) holoenzymes containing either PROTEIN , PROTEIN2 , or PROTEIN .
1	PROTEIN1 was first characterized as a receptor for PROTEIN2 , PROTEIN , and PROTEIN , and was rapidly shown to be the main coreceptor for M-tropic human immunodeficiency virus ( HIV ) -1 strains and simian immunodeficiency virus ( SIV ) .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN1PROTEIN2/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	However , MIP-1 beta was also an agonist for PROTEIN1 but not CC CKR1 ; PROTEIN was an agonist for PROTEIN2 but not CC CKR3 .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/PROTEIN1PROTEIN2 heterodimers , consistent with the reported function of QM/Jif-1 .
1	As observed with the homologous Drosophila proteins , PROTEIN1 interacts directly with PROTEIN2 ; however , additional interactions between PROTEIN and PROTEIN or PROTEIN were detected .
0	We found that in addition to PROTEIN , PROTEIN1 , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	PROTEIN1 expressed in an IL-3-dependent mouse pro-B cell line ( Ba/F3 ) binds PROTEIN with high affinity ( 200 to 250 pM ) , and the transfected cells exhibit a proliferative response to PROTEIN2 .
0	The predicted amino acid sequence of PROTEIN1 is 60 % identical and 73 % similar to mouse PROTEIN ( PROTEIN2 ) .
0	PROTEIN interacts with PROTEIN1 in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN and PROTEIN2 in the incorporation of U2 snRNP into the spliceosome .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and PROTEIN1/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also PROTEIN2/ PROTEIN ) oligomers in the absence of ligand .
0	PROTEIN1 SC1 was derived by linking the two peptide chains of the PROTEIN2 dimer by a seven-residue linker and changing His111 in the first chain to an aspartic acid residue .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/PROTEIN1 , BR-Ia/ PROTEIN2 , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	PROTEIN1 expressed in an PROTEIN2-dependent mouse pro-B cell line ( Ba/F3 ) binds PROTEIN with high affinity ( 200 to 250 pM ) , and the transfected cells exhibit a proliferative response to PROTEIN .
0	PROTEIN was also shown to cleave the precursor of PROTEIN1 inducing factor ( PROTEIN ) at the authentic processing site with high efficiency , thereby activating PROTEIN2 and facilitating its export .
1	Competitive binding of PROTEIN and PROTEIN1 to the PROTEIN2 .
0	Collectively , the novel function of PROTEIN1 via QM/Jif-1 influences PROTEIN2-mediated transcription and apoptosis .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN1PROTEIN2 , indicating that PROTEIN uses components of the PROTEIN receptor .
0	This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN R alpha and PROTEIN1PROTEIN2 and PROTEIN R beta into a complex competent for eliciting biological activity .
0	This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN R alpha and PROTEIN1PROTEIN2 is sufficient to recruit PROTEIN R alpha and PROTEIN R beta into a complex competent for eliciting biological activity .
1	We have engineered and purified recombinant PROTEIN1 head and PROTEIN2 tail , and we demonstrate direct interaction in vitro by solution-binding assays and by ligand blot assays .
0	However , MIP-1 beta was also an agonist for CC CKR3 but not PROTEIN1 ; PROTEIN2 was an agonist for CC CKR1 but not CC CKR3 .
1	PROTEIN1 binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the NMDA receptor , and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain .
0	The substrate specificity , the expression pattern of this kinase , and the ability to deplete 50 % of this kinase activity with a CDK6-specific antibody suggest that the PROTEIN1PROTEIN2-specific antibody suggest that the PROTEIN protein mediates , in part , the p27-associated Rb-kinase activity .
0	This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN1 and PROTEIN2 into a complex competent for eliciting biological activity .
0	Eosinophils undergo chemotaxis , degranulate , and exhibit [ C2+ ] i changes in response to the human CC chemokines macrophage inflammatory protein ( PROTEIN ) -1 alpha , regulated on activation , normal T expressed and secreted ( PROTEIN ) , and PROTEIN1 ( PROTEIN2 ) , but the receptors involved have not been defined .
0	PROTEIN and PROTEIN1 were diminished in the sera of PROTEIN2-/- mice exposed to Propionibacterium acnes and lipopolysaccharide .
0	PROTEIN expressed in an PROTEIN1-dependent mouse pro-B cell line ( Ba/F3 ) binds PROTEIN2 with high affinity ( 200 to 250 pM ) , and the transfected cells exhibit a proliferative response to PROTEIN .
0	The BMP receptors belong to the family of serine/threonine kinase receptors , whose activation has been investigated intensively for the PROTEIN1 ( PROTEIN2 ) receptor subfamily .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( PROTEIN1/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , PROTEIN2/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN1PROTEIN2 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/PROTEIN1 , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also PROTEIN2/ PROTEIN ) oligomers in the absence of ligand .
1	In addition , PROTEIN1 associates with three different CDKs : PROTEIN , PROTEIN , and PROTEIN2 .
0	Collectively , the novel function of PROTEIN via QM/Jif-1 influences PROTEIN1PROTEIN2 influences c-jun-mediated transcription and apoptosis .
0	Isothermal titration calorimetry shows that PROTEIN1PROTEIN2 forms a 1:1 complex with its high-affinity receptor ( PROTEIN R alpha ) with an affinity of 27 ( +/- 9 ) nM .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1PROTEIN2 receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	PROTEIN , a member of the spectrin/PROTEIN1PROTEIN2 , a member of the spectrin/dystrophin family of actin-binding proteins , is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN .
0	These findings imply that PROTEIN1 and PROTEIN share similar early signaling events with the possibility of using the same signal transducer , PROTEIN2 .
1	We show that the carboxy terminal `` tail '' of PROTEIN1 associates directly with the amino terminal `` head '' of type II epidermal keratins , including PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN .
1	PROTEIN1 was also shown to cleave the precursor of PROTEIN2 ( PROTEIN ) at the authentic processing site with high efficiency , thereby activating PROTEIN and facilitating its export .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S PROTEIN1 , which suggests a function for PROTEIN and PROTEIN2 in the incorporation of U2 snRNP into the spliceosome .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN1 , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of PROTEIN1PROTEIN2 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
0	PROTEIN , a member of the spectrin/PROTEIN1 family of actin-binding proteins , is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN2 .
0	Immunoelectronmicroscopic analysis showed that QM/PROTEIN1 and PROTEIN2 are colocalized at the endoplasmic reticulum , and the nuclear matrix in human brain neurons .
0	These data are consistent with a model wherein cyclin D/CDK complexes sequester the PROTEIN1-dependent kinase inhibitory activity of PROTEIN2 .
1	In vitro and in nonproliferating cells , PROTEIN1 associates with and inhibits cyclin/cycin-dependent kinase ( CDK ) holoenzymes containing either PROTEIN , PROTEIN , or PROTEIN2 .
0	Coexpression of the alpha and betaL subunits of the human interferon alpha ( PROTEIN1PROTEIN2 ( PROTEIN ) receptor is required for the induction of an antiviral state by human PROTEIN .
1	We screened for proteins that bind to PROTEIN1 from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the QM/PROTEIN2 gene .
1	The PROTEIN1 associates with the PROTEIN2 catalytic subunit .
1	In vitro-binding assays demonstrated that PROTEIN1 isoforms preferentially bind the hypophosphorylated form of PROTEIN2 .
1	We show that the physical interaction between PROTEIN1 and PROTEIN2 , a coactivator for PROTEIN , is not sufficient for repression of CREB-mediated transcription .
0	The cytokine , designated PROTEIN ( PROTEIN1PROTEIN2 ( PROTEIN ) , is produced by a wide variety of cells and tissues and shares many biological properties with PROTEIN .
0	cDNA clones encoding a human PROTEIN ( PROTEIN1PROTEIN2 ( PROTEIN ) from a Burkitt lymphoma cell line , BJAB , express a 90 to 110 kDa polypeptide in COS7 cells that binds PROTEIN specifically .
0	Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN binding , although with variable potencies ; maximal PROTEIN1PROTEIN2 binding could also compete for monomeric PROTEIN binding , although with variable potencies ; maximal PROTEIN binding inhibition was 80 % for PROTEIN , but only 30 % for PROTEIN .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( PROTEIN1/BR-II , PROTEIN2/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Using several complementary approaches , we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors ( PROTEIN1 and PROTEIN2 ) and the BMP type II receptor ( PROTEIN ) .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
1	Here we show that QM/PROTEIN1 , a negative regulator of PROTEIN2 , is a candidate to mediate the function of PROTEIN in the cell .
0	Immunoelectronmicroscopic analysis showed that PROTEIN1/Jif-1 and PROTEIN2 are colocalized at the endoplasmic reticulum , and the nuclear matrix in human brain neurons .
0	By monitoring fluorescent recombinant protein and by gel mobility shift assays , PROTEIN was shown to accelerate the translocation of PROTEIN from the cytoplasm to the nucleus and to thereby suppress the binding of PROTEIN1PROTEIN2 was shown to accelerate the translocation of PROTEIN from the cytoplasm to the nucleus and to thereby suppress the binding of PROTEIN homodimer to 12-O-tetradecanoylphorbol-13- acetate ( TPA ) -responsive element ( TRE ) .
0	PROTEIN interacts with PROTEIN1 in the presence of PROTEIN to generate a structure similar to 17S PROTEIN2 , which suggests a function for PROTEIN and PROTEIN in the incorporation of U2 snRNP into the spliceosome .
1	Here we show that PROTEIN1/Jun-interacting factor ( Jif ) -1 , a negative regulator of PROTEIN2 , is a candidate to mediate the function of PROTEIN in the cell .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN1 , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN2 .
0	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN1PROTEIN2 with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN .
1	We also found another PROTEIN , PROTEIN1 , interacted with PROTEIN2 .
0	The amount of PROTEIN and PROTEIN associated with PROTEIN1 does not change in a cell cycle-dependent fashion ; in contrast , the amount of PROTEIN associated with PROTEIN2 is lowest in early G1 cells and increases to a maximum in mid-G1 phase , reaching a steady-state level in late G1-phase cells .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN1 , BR-Ib/ PROTEIN2 , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Collectively , the novel function of PROTEIN via PROTEIN1/PROTEIN2 influences c-jun-mediated transcription and apoptosis .
0	Among these ligands , PROTEIN had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN1PROTEIN2 had the remarkable property of binding PROTEIN with high affinity without eliciting a functional response , PROTEIN could also inhibit the activation of PROTEIN by PROTEIN and may therefore be considered as a natural antagonist for PROTEIN .
1	When [ Ca2+ ] i changes were monitored in stably transfected human embryonic kidney 293 cells , ( PROTEIN ) -1 alpha PROTEIN and PROTEIN1 were both potent agonists for PROTEIN2 and CC CKR1 .
1	We found that in addition to PROTEIN , PROTEIN1 , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -PROTEIN2 binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
1	The binding of PROTEIN1 and PROTEIN requires distinct domains of PROTEIN2 .
0	PROTEIN interacts with PROTEIN1 in the presence of PROTEIN2 to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN and PROTEIN in the incorporation of U2 snRNP into the spliceosome .
0	These results demonstrate that PROTEIN and PROTEIN utilize different ligand binding proteins , but share common signal transducer , PROTEIN1PROTEIN2 utilize different ligand binding proteins , but share common signal transducer , PROTEIN , in TF-1 cells .
0	The similarities in biofunctions and differences in ligand binding proteins between PROTEIN and PROTEIN1 prompted us to investigate whether PROTEIN2 shares common signal transduction mechanisms with PROTEIN .
0	The AB loops of PROTEIN SC1 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the IFN-gamma/PROTEIN1PROTEIN2 R alpha complex .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and PROTEIN1/BR-Ib ) and homomeric ( BR-II/BR-II , PROTEIN2/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	PROTEIN1 and PROTEIN2 were diminished in the sera of ICE-/- mice exposed to Propionibacterium acnes and lipopolysaccharide .
1	The binding of PROTEIN and PROTEIN1 requires distinct domains of PROTEIN2 .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN1PROTEIN2 ) has been designed and characterized .
0	Activation of PROTEIN1PROTEIN2 mediated by PROTEIN converting enzyme .
0	Mouse PROTEIN does not bind to PROTEIN1 , and hIL-10R-expressing Ba/F3 cells do not respond to the mouse cytokine , observations consistent with the known species specificity of PROTEIN2 .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( PROTEIN1/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also PROTEIN2/ PROTEIN ) oligomers in the absence of ligand .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S PROTEIN1 , which suggests a function for PROTEIN and PROTEIN in the incorporation of PROTEIN2 into the spliceosome .
0	A region of the beta subunit of the PROTEIN1 receptor different from box 1 interacts with PROTEIN and is sufficient to activate the PROTEIN2-Stat pathway and induce an antiviral state .
0	Mouse PROTEIN does not bind to PROTEIN , and PROTEIN1-expressing Ba/F3 cells do not respond to the mouse cytokine , observations consistent with the known species specificity of PROTEIN2 .
0	The AB loops of PROTEIN SC1 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the IFN-gamma/PROTEIN1PROTEIN2 observed in the crystal structure of the IFN-gamma/IFN-gamma R alpha complex .
0	The AB loops of PROTEIN SC1 adopt conformations similar to the ordered loops of PROTEIN observed in the crystal structure of the IFN-gamma/PROTEIN1PROTEIN2/IFN-gamma R alpha complex .
0	It was observed that anti-gp130 antibodies abolished cell proliferation , protein tyrosine phosphorylation , and PROTEIN gene expression elicited by PROTEIN or PROTEIN1PROTEIN2 antibodies abolished cell proliferation , protein tyrosine phosphorylation , and PROTEIN gene expression elicited by PROTEIN or PROTEIN in TF-1 cells .
0	PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN1 , and can be immunoprecipitated with NMDA receptors and PROTEIN2 from rat brain .
0	PROTEIN was also shown to cleave the precursor of PROTEIN1 ( PROTEIN ) at the authentic processing site with high efficiency , thereby activating PROTEIN2 and facilitating its export .
1	A mutant form of human PROTEIN ( PROTEIN1 ) that binds one PROTEIN2 ( PROTEIN R alpha ) has been designed and characterized .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/PROTEIN1 and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also PROTEIN2/ PROTEIN ) oligomers in the absence of ligand .
0	Monoclonal antibodies to the beta chain of the PROTEIN1 receptor inhibited the biological activity of PROTEIN , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN2 uses components of the PROTEIN receptor .
0	However , the various PROTEIN1/DP complexes display strong differences in the ability to bind to either PROTEIN or PROTEIN2 in vivo , and the specificity of PROTEIN or PROTEIN binding is mediated by the PROTEIN subunit .
0	This region of the betaL chain , required for PROTEIN1 binding and activation , contains the Box 1 motif that is important for the interaction of some cytokine receptors with PROTEIN2 kinases .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN1 , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN2 uses components of the PROTEIN receptor .
0	This transcriptional activity is inhibited by association with the retinoblastoma tumor suppressor protein ( PROTEIN ) or its relatives PROTEIN and PROTEIN1PROTEIN2 ) or its relatives PROTEIN and PROTEIN .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN1PROTEIN2 interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN and PROTEIN in the incorporation of U2 snRNP into the spliceosome .
0	Coexpression of the alpha and betaL subunits of the human PROTEIN1 is required for the induction of an antiviral state by human PROTEIN2 .
0	Involvement of PROTEIN1 signal transducer PROTEIN in PROTEIN2-mediated signal transduction .
0	The cytokine , designated PROTEIN ( PROTEIN ) , is produced by a wide variety of cells and tissues and shares many biological properties with PROTEIN1PROTEIN2 ( PROTEIN ) , is produced by a wide variety of cells and tissues and shares many biological properties with PROTEIN .
0	Coexpression of the alpha and betaL subunits of the human interferon alpha ( PROTEIN1PROTEIN2 is required for the induction of an antiviral state by human PROTEIN .
0	A mutant form of human PROTEIN ( PROTEIN1 ) that binds one PROTEIN2 receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
1	cDNA clones encoding a human PROTEIN1 ( PROTEIN ) from a Burkitt lymphoma cell line , BJAB , express a 90 to 110 kDa polypeptide in COS7 cells that binds PROTEIN2 specifically .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1PROTEIN2 SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	Interaction of mammalian splicing factor PROTEIN1 with U2 snRNP and relation of its 60-kD subunit to yeast PROTEIN2 .
1	PROTEIN1 suppresses the function of PROTEIN homodimers via interaction with PROTEIN2/Jif-1 .
0	However , PROTEIN1 was also an agonist for CC CKR3 but not CC CKR1 ; PROTEIN2 was an agonist for CC CKR1 but not CC CKR3 .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN1 , PROTEIN2/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Eosinophils undergo chemotaxis , degranulate , and exhibit [ C2+ ] i changes in response to the human CC chemokines macrophage inflammatory protein PROTEIN1 , regulated on activation , normal T expressed and secreted ( PROTEIN2 ) , and monocyte chemoattractant protein-3 ( PROTEIN ) , but the receptors involved have not been defined .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN1 , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
1	Activation of PROTEIN1 mediated by PROTEIN2 .
1	The amount of PROTEIN and PROTEIN associated with PROTEIN does not change in a cell cycle-dependent fashion ; in contrast , the amount of PROTEIN1 associated with PROTEIN2 is lowest in early G1 cells and increases to a maximum in mid-G1 phase , reaching a steady-state level in late G1-phase cells .
0	We found that in addition to PROTEIN , PROTEIN1 , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
1	PROTEIN1 binds by its central rod domain to the cytoplasmic tail of both PROTEIN and PROTEIN subunits of the PROTEIN2 , and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain .
0	In addition , PROTEIN associates with three different CDKs : PROTEIN1 , PROTEIN , and PROTEIN2 .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN1 , BR-Ib/ PROTEIN , and also PROTEIN2/ PROTEIN ) oligomers in the absence of ligand .
0	Eosinophils undergo chemotaxis , degranulate , and exhibit [ C2+ ] i changes in response to the human CC chemokines macrophage inflammatory protein PROTEIN1 , regulated on activation , normal T expressed and secreted ( PROTEIN ) , and monocyte chemoattractant protein-3 ( PROTEIN2 ) , but the receptors involved have not been defined .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	It was observed that anti-gp130 antibodies abolished cell proliferation , protein tyrosine phosphorylation , and PROTEIN gene expression elicited by PROTEIN1PROTEIN2 antibodies abolished cell proliferation , protein tyrosine phosphorylation , and PROTEIN gene expression elicited by PROTEIN or PROTEIN in TF-1 cells .
0	We also found another PROTEIN1 , PROTEIN2 , interacted with PROTEIN .
0	PROTEIN1 suppresses the function of PROTEIN2 homodimers via interaction with QM/Jif-1 .
0	The structure also reveals the final six C-terminal amino acid residues of PROTEIN1PROTEIN2 ( residues 253-258 ) that have not been observed in any other reported PROTEIN structures .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN1PROTEIN2/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
1	However , MIP-1 beta was also an agonist for CC CKR3 but not CC CKR1 ; PROTEIN1 was an agonist for PROTEIN2 but not CC CKR3 .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1PROTEIN2 SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	The predicted amino acid sequence of PROTEIN is 60 % identical and 73 % similar to mouse PROTEIN1 ( PROTEIN2 ) .
0	Collectively , the novel function of PROTEIN via PROTEIN1PROTEIN2 via QM/Jif-1 influences c-jun-mediated transcription and apoptosis .
0	A region of the beta subunit of the PROTEIN1PROTEIN2 different from box 1 interacts with PROTEIN and is sufficient to activate the Jak-Stat pathway and induce an antiviral state .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN1 , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
1	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , PROTEIN1/ PROTEIN2 , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	We found that in addition to PROTEIN1 , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by c-Jun/c-Jun but not by PROTEIN1PROTEIN2/c-Jun but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN1 , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Presenilin 1 suppresses the function of PROTEIN homodimers via interaction with QM/PROTEIN1PROTEIN2 homodimers via interaction with QM/Jif-1 .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( PROTEIN1/BR-Ia and PROTEIN2/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/PROTEIN1 ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN2 , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Finally , anti-IL-6R antibody inhibited the ability of PROTEIN1PROTEIN2 antibody inhibited the ability of PROTEIN , but not PROTEIN , to transduce early signals in TF-1 cells .
0	Despite binding to only one PROTEIN1PROTEIN2 R alpha , PROTEIN SC1 is biologically active in cell proliferation , MHC class I induction , and anti-viral assays .
1	The amount of PROTEIN and PROTEIN1 associated with PROTEIN2 does not change in a cell cycle-dependent fashion ; in contrast , the amount of PROTEIN associated with PROTEIN is lowest in early G1 cells and increases to a maximum in mid-G1 phase , reaching a steady-state level in late G1-phase cells .
1	PROTEIN1 interacts with PROTEIN2 in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN and PROTEIN in the incorporation of U2 snRNP into the spliceosome .
0	Activation of PROTEIN1 inducing factor mediated by PROTEIN2 converting enzyme .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( PROTEIN1/BR-II , BR-Ia/ PROTEIN2 , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 ( also known as the MIP-1 alpha/PROTEIN1PROTEIN2/RANTES receptor ) .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and PROTEIN1/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN2 , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	The similarities in biofunctions and differences in ligand binding proteins between PROTEIN1 and PROTEIN prompted us to investigate whether PROTEIN2 shares common signal transduction mechanisms with PROTEIN .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN1PROTEIN2 interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN and PROTEIN in the incorporation of U2 snRNP into the spliceosome .
1	Isothermal titration calorimetry shows that PROTEIN1 forms a 1:1 complex with its high-affinity receptor ( PROTEIN2 ) with an affinity of 27 ( +/- 9 ) nM .
0	Moreover , similar PROTEIN sequences are required for binding PROTEIN1 and PROTEIN2 .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN , and PROTEIN1 competed for binding with PROTEIN , indicating that PROTEIN2 uses components of the PROTEIN receptor .
0	Coexpression of the alpha and betaL subunits of the human PROTEIN1PROTEIN2 ( PROTEIN ) receptor is required for the induction of an antiviral state by human PROTEIN .
0	PROTEIN , a member of the spectrin/dystrophin family of PROTEIN1-binding proteins , is identified here as a brain postsynaptic density protein that colocalizes in dendritic spines with NMDA receptors and the putative NMDA receptor-clustering molecule PROTEIN2 .
0	Here we demonstrate that DP is also a family of polypeptides with at least two members ( PROTEIN1 and PROTEIN2 ) .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/PROTEIN1 and BR-II/BR-Ib ) and homomeric ( BR-II/PROTEIN2 , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
1	The binding of PROTEIN1/Jif-1 to full-length PROTEIN2 was confirmed in vitro by pull-down assay , and in vivo by immunoprecipitation assays with human samples , including AD brains .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN1PROTEIN2 .
0	Furthermore , the amount of PROTEIN1 is significantly lower than the amount of PROTEIN2 in these cells .
0	Using several complementary approaches , we investigated the formation of homomeric and heteromeric complexes between the two known BMP type I receptors ( PROTEIN and PROTEIN ) and the PROTEIN1 ( PROTEIN2 ) .
0	In addition , PROTEIN associates with three different CDKs : PROTEIN1 , PROTEIN2 , and PROTEIN .
1	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -PROTEIN1 binding : PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Eosinophils undergo chemotaxis , degranulate , and exhibit [ C2+ ] i changes in response to the human CC chemokines macrophage inflammatory protein ( PROTEIN ) -1 alpha , regulated on activation , normal T expressed and secreted ( PROTEIN ) , and PROTEIN1PROTEIN2 ) , and monocyte chemoattractant protein-3 ( PROTEIN ) , but the receptors involved have not been defined .
0	Both PROTEIN1 and PROTEIN2 bind to all PROTEIN family members in vivo , and each complex is capable of activating transcription .
0	PROTEIN binds by its central rod domain to the cytoplasmic tail of both PROTEIN1 and PROTEIN2 subunits of the NMDA receptor , and can be immunoprecipitated with NMDA receptors and PROTEIN from rat brain .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/BR-Ib ) and homomeric ( BR-II/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN1PROTEIN2/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	This suggests that one domain of PROTEIN is sufficient to recruit PROTEIN R alpha and PROTEIN1PROTEIN2 R alpha and PROTEIN R beta into a complex competent for eliciting biological activity .
0	We screened for proteins that bind to PROTEIN from a human embryonic brain cDNA library using the two-hybrid method and isolated one clone encoding the PROTEIN1/PROTEIN2 gene .
0	The similarities in biofunctions and differences in ligand binding proteins between PROTEIN and PROTEIN1 prompted us to investigate whether PROTEIN shares common signal transduction mechanisms with PROTEIN2 .
0	Chemokines that could compete with high affinity for PROTEIN binding could also compete for monomeric PROTEIN binding , although with variable potencies ; maximal PROTEIN binding inhibition was 80 % for PROTEIN1PROTEIN2 binding , although with variable potencies ; maximal PROTEIN binding inhibition was 80 % for PROTEIN , but only 30 % for PROTEIN .
0	A mutant form of human PROTEIN ( PROTEIN SC1 ) that binds one PROTEIN1PROTEIN2 SC1 ) that binds one PROTEIN receptor alpha chain ( PROTEIN R alpha ) has been designed and characterized .
0	Activation of PROTEIN inducing factor mediated by PROTEIN1PROTEIN2 mediated by PROTEIN converting enzyme .
0	We found that in addition to PROTEIN , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
1	Chloramphenicol acetyltransferase assays in F9 cells showed that PROTEIN suppresses transactivation by PROTEIN1/PROTEIN2 but not by c-Jun/c-Fos heterodimers , consistent with the reported function of QM/Jif-1 .
0	The PROTEIN ( PROTEIN1 ) converting enzyme ( PROTEIN ) processes the inactive PROTEIN2 precursor to the proinflammatory cytokine .
1	cDNA clones encoding a human PROTEIN ( PROTEIN1 ) from a Burkitt lymphoma cell line , BJAB , express a 90 to 110 kDa polypeptide in COS7 cells that binds PROTEIN2 specifically .
0	In the assembly of a prespliceosome , PROTEIN1 ( snRNP ) functions in pre-messenger RNA ( mRNA ) splicing together with splicing factors ( SFs ) 3a , PROTEIN2 , and several other proteins .
0	These results demonstrate that PROTEIN1 and PROTEIN utilize different ligand binding proteins , but share common signal transducer , PROTEIN2 , in TF-1 cells .
0	We found that in addition to PROTEIN1 , PROTEIN , and PROTEIN , five other CC-chemokines could compete for [ ( 125 ) I ] -MIP-1beta binding : PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN binding was characterized by IC ( 50 ) values of 0.22 , 2.14 , 5.89 , 29.9 , and 21.7 nmol/L , respectively .
0	Here we show that QM/Jun-interacting factor ( Jif ) -1 , a negative regulator of PROTEIN1 , is a candidate to mediate the function of PROTEIN2 in the cell .
0	This transcriptional activity is inhibited by association with the PROTEIN1 ( PROTEIN ) or its relatives PROTEIN2 and PROTEIN .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( BR-II/BR-Ia and BR-II/PROTEIN1 ) and homomeric ( BR-II/PROTEIN2 , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	Isothermal titration calorimetry shows that PROTEIN1 SC1 forms a 1:1 complex with its high-affinity receptor ( PROTEIN2 R alpha ) with an affinity of 27 ( +/- 9 ) nM .
0	Monoclonal antibodies to the beta chain of the PROTEIN receptor inhibited the biological activity of PROTEIN , and PROTEIN competed for binding with PROTEIN , indicating that PROTEIN uses components of the PROTEIN1PROTEIN2 , indicating that PROTEIN uses components of the PROTEIN receptor .
0	Activation of PROTEIN inducing factor mediated by PROTEIN1PROTEIN2 .
0	Using antibody-mediated immunofluorescence copatching of epitope-tagged receptors , we provide evidence in live cells for preexisting heteromeric ( PROTEIN1/BR-Ia and BR-II/BR-Ib ) and homomeric ( PROTEIN2/BR-II , BR-Ia/ PROTEIN , BR-Ib/ PROTEIN , and also BR-Ia/ PROTEIN ) oligomers in the absence of ligand .
0	PROTEIN interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN and PROTEIN1PROTEIN2 interacts with U2 snRNP in the presence of PROTEIN to generate a structure similar to 17S U2 snRNP , which suggests a function for PROTEIN and PROTEIN in the incorporation of U2 snRNP into the spliceosome .
